CV Lattes
Secretaria de Desenvolvimento Econômico (São Paulo - Estado). Instituto de Pesquisas Energéticas e Nucleares (IPEN) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Pharmacyst by University of São Paulo (1987). MSc (1991) and PhD (1995) degree in Radiopharmacy area at Nuclear and Energy Research Institute (IPEN-CNEN), a pos graduation unit of the University of São Paulo. Researcher and professor of the pos graduation program of IPEN-USP and Professional MSc program of IPEN. Experience in radiopharmaceutical development, production, quality control and quality assurance of radiopharmaceuticals, working in the development of radiopharmaceuticals for diagnostic and therapy, quality assurance applied to the production and quality control of radiopharmaceuticals, good manufacturing practices and registration of radiopharmaceuticals. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The Scientific and Technological Qualification refers to the necessary adaptation to the development of new radiopharmaceuticals, specifically in the phase of scheduling until pilot, within the required quality standards. In addition, one must consider safety issues for manipulation of high radioactive activities, compatible with the scale of industrial production, making it possible to c…
In Brazil, prostate cancer (PC) is the second most common cancer among men, where the disease has treatments ranging from surgery to radiotherapy. Currently, several imaging exams such as positron emission tomography associated with computed tomography are used for the identification and evaluation of cancer. Today it has several specific radiotracers where prostate-specific membrane anti…
Neuroendocrine tumors represent a heterogeneous group of carcinomas, which originate in neural and endocrine cells and whose incidence and prevalence has increased over the last decades. Currently, gallium-68-labeled somatostatin analogues, such as 68Ga-DOTATOC [DOTA-D-Phe1-Tyr3-ocreotide] 68Ga-DOTANOC [1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid]-1-Na13-ocreotide], 68Ga-DOTA…
The PSMA is a specific prostatic membrane antigen (glycoprotein type 2) found in the membrane or cytoplasm of the Prostate Cancer cell and has been targeted for treatment of this disease. The discovery of PSMA allowed the creation of novel substances that bind specifically to the antigen and results into more efficient therapies for non-responsive cases, especially of cancer that is not r…
(Only some records are available in English at this moment)
| 1 / 1 | Completed research grants |
| 7 / 5 | Completed scholarships in Brazil |
| 8 / 6 | All research grants and scholarships |
| Associated processes | |